ALO moving after hours hope we get a move up in ANPI and maybe AAII as well Maybe a "drug approval" surge in the pharmies again.
On the biotech front, shares of Alpharma (ALO: news, chart, profile) surged $5.24, or 28 percent, to $24 after the generic-drug maker said it received final FDA approval for a version of Neurontin, Pfizer's epilepsy drug. In the regular session, the stock closed up 69 cents at $18.83.